In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypanosoma cruzi population

Parasite Immunology

Volumn 21, Issue 10, 1999, Pages 535-544

  Murta, S M F ^a,b   Ropert, C ^b   Alves, R O ^b   Gazzinelli, R T ^a,b   Romanha, A J ^b  

^a UFMG   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chaga's disease; Drug resistance; Interferon gamma; Interleukin 12; Nitric oxide; Trypanosoma cruzi; Tumour necrosis factor alpha

Indexed keywords

BENZNIDAZOLE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG RESISTANCE; INTERFERON PRODUCTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITE CONTROL; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

ANIMALS; CHAGAS DISEASE; CYTOKINES; DRUG RESISTANCE; INTERLEUKIN-12; MACROPHAGES; MALE; MICE; NITRIC OXIDE; NITROIMIDAZOLES; PARASITEMIA; PHAGOCYTOSIS; TRYPANOCIDAL AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032867161     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1999.00251.x     Document Type: Article

References (42)

1. Alibert J.C.A., Cardoso M.A.G., Martins G.A. et al. (1996) IL-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity, 64, 1961-1967
2. Berger B.J. & Fairlamb A.H. (1992) Interactions between immunity and chemotherapy in the treatment of the trypanosominases and leishmaniases. Parasitology, 105, 871-878
3. Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry, 72, 248-254
4. Brener Z. (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo, 4, 389-396
5. Brener Z. & Gazzinelli R.T. (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas disease. International Archives of Allergy and Immunology, 114, 103-110
6. Brindley P.J. & Sher A. (1987) The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. Journal of Immunology, 139, 215-220
7. Camargo E.P. (1964) Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosome in liquid media. Revista do Instituto de Medicina Tropical de São Paulo, 6, 93-100
8. Camargo M.M., Almeida I.C., Pereira M.E. t al. (1997) Glycosylpho-sphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. Journal of Immunology, 158, 5890-5901
9. Cardillo F., Voltarelli J.C., Reed S.G. & Silva J.S. (1996) Regulation of Trypanosma cruzi infection in mice by gamma interferon and interleukin-10: the role of NK cells. Infection and Immunity, 64, 128-134
10. Carneiro M., Chiari E., Gonçalves A.M. et al. (1990) Changes in the isoenzyme and kinetoplast DNA patterns of Trypanosoma cruzi strains induced by maintenance in mice. Acta Tropica, 47, 35-45
11. Clemons K.V., Brummer E. & Stevens D.A. (1994) Cytokine treatment of central nervous system infection: efficacy of IL-12 alone and synergy with conventional antifugal therapy in experimental cryptococcoses. Antimicrobial Agents and Chemotherapy, 38, 460-464
12. Degee A.L.W., McCann P. & Mansfield J.M. (1983) Role of antibody in the elimination of trypanosomes after DL-α-difluoromethylornithine chemotherapy. Journal of Parasitology, 69, 818-822
13. Drapier J.C., Wietzerbin J. & Hibbs J.B. Jr (1988) Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. European Journal of Immunology, 18, 1587
14. Filardi L.S. & Brener Z. (1984) A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Memórias do Instituto Oswaldo Cruz, 79, 221-225
15. Filardi L.S. & Brener Z. (1987) Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 755-759
16. Flynn J.L., Goldstein M.M., Triebold K.J. et al. (1995) IL-12 increases resistance of Balb/c mice to Mycobacterium tuberculosis infection. Journal of Immunoloy, 155, 2515-2524
17. Fontes G., Romanha A.J., Pereira M.E. & Brener Z. (1991) Lectin receptors distribution in the surface membrane of Trypanosoma cruzi blood forms collected from mice submitted to specific treatment. Memórias do Instituto Oswaldo Cruz, 86, 297-299
18. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S. & Sher A. (1993) Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell deficient hosts. Proceedings of the National Academy of Sciences USA, 90, 6115-6119
19. Gazzinelli R.T., Oswald P., Hieny S., James S.L. & Sher A. (1992) The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mechanism inhabitable by interleukin-10 and transforming growth factor-β. European Journal of Immunology, 22, 2501-2506
20. Hunter C.A., Slifer T. & Araujo F. (1996) Interleukin-12 mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infection and Immunity, 64, 2381-2386
21. Khaw M. & Panosian C.B. (1995) Human antiprotozoal therapy: past, present, and future. Clinical Microbiology Review of, 8, 427-439
22. Lages-Silva E., Filardi L. & Brener Z. (1990) Effect of the host specific treatment in the phagocytosis of Trypanosoma cruzi blood forms by mouse peritoneal macrophages. Memórias do Instituto Oswaldo Cruz, 85, 401-405
23. Michailowsky V., Murta S.M.F., Carvalho-Oliveira L. et al. (1998) Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy, 42, 2549-2556
24. Muller L.A., Anasco N. & Gonzales Cappa S.M. (1986) Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse. Experimental Parasitology, 61, 284-293
25. Murta S.M.F., Gazzinelli R.T., Brener Z. & Romanha A.J. (1998) Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Molecular and Biochemical Parasitology, 93 (2), 203-214
26. Murta S.M.F. & Romanha A.J. (1998) In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology, 116, 165-171
27. Nabors G.S., Alonso L.C.C., Farrell J.P. & Scott P. (1995) A switch from a Th2 to Th1 type response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proceedings of the National Academy of Sciences, USA, 92, 3142-3146
28. Neal R.A. & Van Bueren J. (1988) Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 709-714
29. Pereira da Silva L.H.P. & Nussenzweig V. (1953) Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongo branco. Folia Clinica et Biologica, 20, 191-207
30. Reed S.G. (1988) In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. Journal of Immunology, 140, 4342-4347
31. Ribeiro-Rodrigues R., Dos Santos W., Oliveira A.B. et al. (1995) Growth inhibitory effect of nafthofuran and nafthofuranquinone derivatives on Trypanosoma cruzi epimastigotes. Bioorganic and Medicinal Chemistry Letters, 5, 1509-1512
32. Scoth V.R. & Mathews T.R. (1987) The efficacy of an n-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. American Journal of Tropical Medicine and Hygiene, 37, 308-313
33. Silva J.S., Morrissey P.J., Grabstein K.H. et al. (1992) Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. Journal of Experimental Medicine, 175, 169-174
34. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Alibert J.C.S. & Cunha F.Q. (1995) Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity, 63 (12), 4862-4867
35. Steindel M., Dias Neto E., Menezes C.L.P., Romanha A.J. & Simpson A.J.G. (1993) Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Molecular and Biochemical Parasitology, 60, 71-80
36. Stevenson M.M., Tam M.F., Wolf S.F. & Sher A. (1995) IL-12-induced protection against blood-stage Plasmodium chabaudi requires IFNγ and TNFα and occurs via nitric oxide-dependent mechanism. Journal of Immunology. 156, 263-268
37. Target G.A.T. (1985) Chemotherapy and the immune response in parasitic infections. Parasitology, 90, 661-673
38. Toledo M.J.O., Machado G.B.N., Pereira M.E.S. & Brener Z. (1991) Results of treatment in mice immunosuppressed inoculated with different Trypanosoma cruzi strains. Memórias do Instituto Oswaldo Cruz, 86, 237
39. Torrico F., Heremans H., Rivera M.T. et al. (1991) Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology. 146, 3626-3632
40. Vespa G.N.R., Cunha F.Q. & Silva J.S. (1994) Nitric oxide is involved in the control of Trypanosoma cruzi induced parasitemia and directly kills parasite in vitro. Infection and Immunity, 62, 5177-5182
41. World Health Organization (1994) Chagas Disease, WHO Technical Report Series, TDR News, p. 125-134
42. Zhou P., Sieve M.C., Tewari R.P. & Seder R.A. (1997) Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulation. Infection and Immunity, 65, 1-7